These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people.

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy.

Understanding causes of death among men with prostate cancer recurrence after localized treatment is essential for informed decision-making.

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

“The largest absolute increases in early-onset cancers were observed for female breast, colorectal, kidney, and uterine cancers,” the researchers wrote. The incidence of early-onset cancers in ...

Sleep is shorter on hemodialysis treatment days with shorter sleep durations associated with worse survival. Poor sleep quality increases the risk for early mortality among patients receiving ...

Unlike in the global trials, the US subgroup analysis showed similar MACE risk between vadadustat and darbepoetin in US patients with CKD not on dialysis. Among US trial participants with anemia ...

The study found no significant differences between the groups in terms of disease progression, morbidity or mortality, or all-cause death. Macitentan demonstrated superiority over other endothelin ...